The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
----------
Blackbird PLC - London-based technology licensor, developer and seller of cloud video editing platform - In the six months to June 30, pretax loss narrows slightly to £1.5 million from £1.6 million a year prior. Revenue falls 30% to £691,643 from £985,115, cost of sales declines 35% to £49,681 from £76,268. Loss per share are 0.40 pence compared with 0.44p before. Says revenue fall reflects previously announced deal losses of A+E Networks and Deltatre.
----------
Schroder Asian Total Return Investment Co PLC - investment trust focused on Asia - Net asset value per share rises to 495.91 pence at June 30 compared to 433.74p a year prior. Technology holdings, especially those linked to artificial intelligence, were the largest contributors to performance and benefitted the technology heavy Taiwan market, where stocks rose strongly. ‘Our portfolio managers have an impressive long term track record and their experience, supported by Schroders’ extensive resources in Asia, gives the board confidence in their ability to navigate regional equity markets,’ company says.
----------
Futura Medical PLC - sexual health products company - In the six months to June 30 swings to pretax profit of £866,641 from a loss of £2.0 million a year ago. Revenue multiplies to £7.0 million from £1.7 million, cost of sales jumps to £2.2 million from £794,386. Product sales more than double to £3.8 million from £1.7 million. ‘The board is confident in the outlook for the remainder of the year and confirms that both revenue and profit will significantly exceed market expectations for the full year.’ Puts these at £9.5 million for revenue and £2.6 million for pretax loss.
----------
CPPGroup PLC - Leeds, England-based technology-driven assistance and insurance provider - Completes the disposal of its 51% interest in Globiva Services Private Ltd for around £3.8 million cash. Chief Executive Simon Pyper comments: ‘The accelerated disposal of Globiva is consistent with our strategy and is another positive step as we simplify the group and transform to a digitally led parametric business.’
----------
Tissue Regenix Group PLC - Leeds, England-based regenerative medical devices company - For the six months ended June 30 swings to pretax profit of $0.1 million from loss of $0.9 million a year prior. Revenue rises 16% to $16.4 million from $14.1 million, driven by strong performance in technology platforms BioRinse and dCELL. ‘The management team has done a stellar job of driving the business forward through headwinds in certain segments and continues to identify expansion opportunities geographically as well as through new surgical indications,’ company says. ‘We retain a strong cash position to see us through our current business plans, including the Phase 2 capacity expansion of the group’s facility in San Antonio, which is expected to complete in 2025.’
----------
EnSilica PLC - Oxfordshire, England-based company is a chip maker of mixed signal application specific integrated circuits, or ASICs - Announces that it has now shipped five million ASICs for use in the chassis control unit of a leading automotive company’s premium vehicle, a key delivery milestone.
----------
Lendinvest PLC - London-based non-bank mortgage lender - Extends existing separate account with JP Morgan by £500 million to £1.5 billion. This funding will be used to support the growth of LendInvest’s mortgages proposition. As a result, LendInvest now has more than £4.55 billion of funds under management. ‘This extension will significantly strengthen our already competitive buy-to-let proposition, ensuring we remain at the forefront of the industry through our innovative approach and exceptional customer service,’ company says.
----------
EPE Special Opportunities Ltd - aims to provide long-term return on equity by investing between £2 million and £30 million in small and medium sized companies - Net asset value per share at July 31 is 319 pence, down 1.5% from 324 pence as January 31. ‘Despite continuing macroeconomic challenges, the company has maintained a steady performance in the six months to July 31 2024,’ company says. ‘Although economic indicators provide reasons for cautious optimism, the market for new investments and disposals remains difficult.’ Chair Clive Spears comments: ‘The company’s performance during the recent period has been encouraging despite ongoing macroeconomic disruptions.’
----------
Copyright 2024 Alliance News Ltd. All Rights Reserved.
